(Q36693363)

15 August 2017

1 reference

title

Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review (English)

1 reference

15 August 2017

1 reference

1

Mervyn D I Vergouwen

1 reference

15 August 2017

Marinus Vermeulen

2

1 reference

15 August 2017

Rob J de Haan

series ordinal

3

1 reference

15 August 2017

Marcel Levi

series ordinal

4

1 reference

15 August 2017

Yvo Bwem Roos

series ordinal

5

1 reference

15 August 2017

publication date

27 December 2006

1 reference

Journal of Cerebral Blood Flow & Metabolism

15 August 2017

published in

1 reference

15 August 2017

volume

27

1 reference

15 August 2017

issue

7

1 reference

15 August 2017

page(s)

1293-1308

1 reference

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Platelets synthesize large amounts of active plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Regulation of local availability of active tissue-type plasminogen activator in vivo in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Inhibition of plasminogen activator inhibitor-1 by angiotensin II receptor blockers on cyclosporine-treated renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Calcium-dependent stabilization of type I plasminogen activator inhibitor within platelet alpha-granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Antihypertensive drug treatment and fibrinolytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with hunt-hess grade and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group. Captopril Insulin Sensitivity Multicenter Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: with a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Surgical bleeding: unexpected effect of a calcium antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Fibrinolytic Variables and Cardiovascular Prognosisin Patients With Stable Angina Pectoris Treated With Verapamil or Metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Differential effects of non-specific beta-blockade and calcium antagonism on blood-clotting mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Decreased fibrinolytic activity and increased platelet function in hypertension. Possible influence of calcium antagonism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Association between obesity and a prothrombotic state: the Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

The Role of Endothelium in Cardiovascular Homeostasis and Diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

The effects of chronic smoking on the fibrinolytic potential of plasma and platelets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Hyperglycemia Stimulates Coagulation, Whereas Hyperinsulinemia Impairs Fibrinolysis in Healthy Humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Relationship between endothelial function and fibrinolysis in early hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600431

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600431

1 reference

15 August 2017

1 reference